Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

According to Bitkom, 62 percent of companies transfer personal data to non-EU states. A renunciation would mean higher costs ...

Vulnerable communities in the United States often face the highest risks from individual environmental burdens, such as ...

The accelerating expansion of the universe is usually explained by an invisible force known as dark energy. But a new study ...

We know the genes, but not their functions.” To resolve this long-standing bottleneck in microbial research, a joint research ...

Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...

Analysis of Clinical Characteristics and Treatment Trends in Hospitalized Patients with Cardiovascular Diseases in the Baise ...

Recent research has shown surprising health benefits of coffee, including a reduction in AFib frequency and a decrease in the ...

Tisento Therapeutics today announced that the global Phase 2b PRIZM study is fully enrolled. PRIZM is evaluating zagociguat – a once-daily, oral investigational medicine – as a treatment for the rare ...

SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...

Academics today, around the world, are confined by the way their research output is measured. Indicators that count the ...